Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glofitamab in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
NCT05533775Phase 2Recruiting
- Sponsor
- Roche
- Start
- Nov 2022
- Primary completion
- Nov 2029
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of glofitamab in mature B-cell non-Hodgkin lymphoma, sponsored by Roche. Started Nov 2022; status: recruiting.
02
Drugs
glofitamab
03
Conditions
mature B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT05533775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05533775.